Prevalence of Gestational Diabetes, Risk Factors and its Outcome in a Tertiary Hospital
Nepal Medical College Journal · 2018
DOI: 10.3126/nmcj.v20i4.25136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nepal Medical College Journal, 2018. Verfasst von Biloni Shreshta und 1 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance with onset or first recognition during pregnancy. GDM increases the risk of adverse maternal and perinatal outcome and increases risk of diabetes in mother and child in the future. Prevalence of GDM is increasing all over the world. This is hospital based cross sectional study done in Department of Obstetrics and Gynecology, Nepal Medical College and Teaching Hospital to find out the prevalence of GDM and to trace maternal and fetal risk factors and adverse outcome. In this study, 600 pregnant women were enrolled during 2016-17. Among them 27 (4.5%) were found to have GDM. Among GDM, four (14.4%) were ≥ 35 years old and six (22.2%) had BMI of ≥ 25 kg/m2. Caesarean section was more common mode of delivery in women with GDM than without (51.9% vs 22.2%). Increased prevalence shown in this study necessitates universal screening of GDM.
Zitieren
APA
Shreshta, B., & Shrestha, A. (2018). Prevalence of Gestational Diabetes, Risk Factors and its Outcome in a Tertiary Hospital. Nepal Medical College Journal. https://doi.org/10.3126/nmcj.v20i4.25136
Vancouver
Shreshta B, Shrestha A. Prevalence of Gestational Diabetes, Risk Factors and its Outcome in a Tertiary Hospital. Nepal Medical College Journal. 2018. doi:10.3126/nmcj.v20i4.25136
BibTeX
@article{Shreshta2018,
author = {Shreshta, Biloni and Shrestha, A.},
title = {Prevalence of Gestational Diabetes, Risk Factors and its Outcome in a Tertiary Hospital},
journal = {Nepal Medical College Journal},
year = {2018},
doi = {10.3126/nmcj.v20i4.25136}
}
EUVIMED